BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31622620)

  • 1. International Perspective on the Burden of Colorectal Cancer and Public Health Effects.
    Rabeneck L; Chiu HM; Senore C
    Gastroenterology; 2020 Jan; 158(2):447-452. PubMed ID: 31622620
    [No Abstract]   [Full Text] [Related]  

  • 2. Deciphering the increasing incidence, special characteristics and possible aetiology of early onset colorectal cancer: A European perspective within an international effort.
    Perea J; Balaguer F
    United European Gastroenterol J; 2020 Mar; 8(2):131-132. PubMed ID: 32213064
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimizing the Quality of Colorectal Cancer Screening Worldwide.
    Kaminski MF; Robertson DJ; Senore C; Rex DK
    Gastroenterology; 2020 Jan; 158(2):404-417. PubMed ID: 31759062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for Colorectal Cancer Screening.
    Ladabaum U; Dominitz JA; Kahi C; Schoen RE
    Gastroenterology; 2020 Jan; 158(2):418-432. PubMed ID: 31394083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Organized colorectal cancer screening].
    Rouëssé J; Sancho-Garnier H;
    Bull Acad Natl Med; 2014 Feb; 198(2):387-99. PubMed ID: 26263711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer screening: continuing instability.
    Eisinger F
    Eur J Cancer Prev; 2015 Jun; 24 Suppl():S65-7. PubMed ID: 26016789
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorectal cancer screening: a global overview of existing programmes.
    Schreuders EH; Ruco A; Rabeneck L; Schoen RE; Sung JJ; Young GP; Kuipers EJ
    Gut; 2015 Oct; 64(10):1637-49. PubMed ID: 26041752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward better control of colorectal cancer.
    The Lancet
    Lancet; 2014 Apr; 383(9927):1437. PubMed ID: 24766949
    [No Abstract]   [Full Text] [Related]  

  • 9. A conceptual framework and metrics for evaluating multicomponent interventions to increase colorectal cancer screening within an organized screening program.
    Subramanian S; Hoover S; Tangka FKL; DeGroff A; Soloe CS; Arena LC; Schlueter DF; Joseph DA; Wong FL
    Cancer; 2018 Nov; 124(21):4154-4162. PubMed ID: 30359464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal Cancer Burden and Access to Federally Qualified Health Centers in California.
    Darsie B; Rico J; Gadgil M; Tootoo J
    Prev Chronic Dis; 2015 Oct; 12():E169. PubMed ID: 26447546
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost Effectiveness of Colorectal Cancer Screening Interventions with Their Effects on Health Disparity Being Considered.
    Lee KS; Park EC
    Cancer Res Treat; 2016 Jul; 48(3):1010-9. PubMed ID: 26727714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of colorectal cancer (CRC) screening.
    Cruzado J; Sánchez FI; Abellán JM; Pérez-Riquelme F; Carballo F
    Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):867-80. PubMed ID: 24182607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer: national and international perspective on the burden of disease and public health impact.
    Gellad ZF; Provenzale D
    Gastroenterology; 2010 Jun; 138(6):2177-90. PubMed ID: 20420954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
    Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
    BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.
    Kemper KE; Glaze BL; Eastman CL; Waldron RC; Hoover S; Flagg T; Tangka FKL; Subramanian S
    Cancer; 2018 Nov; 124(21):4121-4129. PubMed ID: 30359468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sociogeographical factors associated with participation in colorectal cancer screening.
    Le Retraite L; Eisinger F; Loundou A; Rinaldi Y; Seitz JF; Auquier P
    Gastroenterol Clin Biol; 2010 Oct; 34(10):534-40. PubMed ID: 20832216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer screening interventions in 2 health care systems serving disadvantaged populations: Screening uptake and cost-effectiveness.
    Lara CL; Means KL; Morwood KD; Lighthall WR; Hoover S; Tangka FKL; French C; Gayle KD; DeGroff A; Subramanian S
    Cancer; 2018 Nov; 124(21):4130-4136. PubMed ID: 30359479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summaries for patients. Screening colonoscopy and colorectal cancer risk.
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):I-48. PubMed ID: 23460070
    [No Abstract]   [Full Text] [Related]  

  • 19. Worldwide burden of colorectal cancer: a review.
    Favoriti P; Carbone G; Greco M; Pirozzi F; Pirozzi RE; Corcione F
    Updates Surg; 2016 Mar; 68(1):7-11. PubMed ID: 27067591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Cancer in Women: Burden and Trends.
    Torre LA; Islami F; Siegel RL; Ward EM; Jemal A
    Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):444-457. PubMed ID: 28223433
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.